abrdn Life Sciences Investors (HQL) earnings date and history
abrdn Life Sciences Investors (HQL) has not announced its next earnings date yet.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on HQL
| Last price | $18.35 (-0.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.7% |
| Dividend | $2.24 a year (12.21% yield) |
These figures come from the same calibrated model and valuation as the abrdn Life Sciences Investors stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
The date is not announced yet; we will email you as soon as it is close. One email the day before, with ATLAS’s read on abrdn Life Sciences Investors. You can switch it off at any time.
Alert me before HQL reportsFree to start. Creating an account takes under a minute.
HQL earnings at a glance
| Next report | Not announced |
|---|---|
| Last report | Jan 7, 2026 · Beat |
| Average EPS surprise | +9.8% |
| Sector | Financial Services · Asset Management |
abrdn Life Sciences Investors earnings history: last 1 reports
abrdn Life Sciences Investors last reported on Jan 7, 2026: EPS of $2.13 against an estimate of $1.94 (+9.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jan 7, 2026 | $1.94 | $2.13 | +9.8% | Beat | +0.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for HQL
See the fair value, the probability range and the earnings history of abrdn Life Sciences Investors on its ATLAS page.
abrdn Life Sciences Investors (HQL) stock analysisPlans from €3.99 a month.
abrdn Life Sciences Investors earnings: frequently asked questions
When is abrdn Life Sciences Investors (HQL) next earnings date?
abrdn Life Sciences Investors has not announced its next report date and there is not enough history to estimate one.
Did abrdn Life Sciences Investors beat earnings estimates last quarter?
abrdn Life Sciences Investors last reported on Jan 7, 2026: EPS of $2.13 against an estimate of $1.94 (+9.8% surprise), a beat.
How much does HQL usually move in a day?
On a normal trading day the ATLAS model puts HQL’s one-day range at about ±1.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer